# Sentinel Beliefs, Doubts, and Must-Prove-Next v1

Status: `draft working memo`

Package root:

- `docs/vision/pharma-control-plane/README.md`

Related notes:

- `docs/vision/pharma-control-plane/current/v1/vision.md`
- `docs/vision/pharma-control-plane/current/v1/system-design.md`
- `docs/vision/pharma-control-plane/current/v1/wedge-validity-assessment.md`
- `docs/vision/pharma-control-plane/current/v1/design-partner-pilot-scorecard.md`
- `docs/vision/pharma-control-plane/current/v1/design-partner-discovery-guide.md`
- `docs/vision/pharma-control-plane/current/v1/pilot-acceptance-plan.md`

## Purpose

This memo captures the current best honest read on Sentinel after repeated narrowing and repeated skeptical review.

It is intentionally blunt.

Its purpose is to separate:

- what now looks genuinely believable
- what still looks fragile or commercially doubtful
- what must be proven next before the vision deserves more confidence

## Current Read

Sentinel looks conceptually much stronger than it did earlier.

The product story is now:

- narrower
- more honest about incumbents
- clearer about what Sentinel does not replace
- clearer about the first recurring matter type
- clearer about the day-one workflow boundary

At the same time, the center of risk has moved.

The main question is no longer:

"do we know what we are trying to build?"

The main question is now:

"does this pain concentrate strongly enough inside a real buyer, budget, and pilot motion to create demand?"

That distinction matters because a real need does not automatically become a buyable product.

## What I Currently Believe

### 1. The underlying problem looks real

The recurring problem of cross-system ownership gaps, fragmented evidence, manual reconciliation, and unclear downstream completion appears real.

It also appears older than the current AI wave, which makes it more credible than a hype-born thesis.

### 2. The narrowed wedge is much more believable

The current wedge is far more defensible than the earlier broader story.

The strongest version is now:

Sentinel coordinates a governed post-intake safety follow-up matter across incumbent systems, teams, and jurisdictions without replacing those systems.

That is a plausible product statement.

### 3. The overlay boundary now makes sense

The docs now clearly say:

- Sentinel does not replace the safety suite
- Sentinel does not become the submission gateway
- Sentinel does not become the primary system of record

That honesty makes the idea stronger, not weaker.

### 4. The current backend direction fits the product better than a flashy prototype would

Durability, replay safety, append-only evidence, and explicit state separation all align well with an orchestration-and-evidence product.

The current technical backbone feels compatible with the serious version of this company.

### 5. AI helps the timing, but should not be the wedge

AI increases the pressure around provenance, review, and governed coordination.

But the buyer pain must exist even without an AI narrative.

That is now a healthier framing.

## What I Currently Doubt

### 1. I do not yet believe the economic buyer is clear

This is the biggest open problem.

The likely operator sponsor is visible.

The actual budget owner is not.

A skeptical buyer could fully agree that the pain is real and still say:

"nobody here can actually buy this."

Until that changes, Sentinel is a plausible wedge but not yet an earned company.

### 2. I do not yet believe the chosen matter type has proven enough demand density

`post-intake cross-market safety follow-up matter` is conceptually strong.

What is still unproven:

- how often it really happens
- how painful it is relative to workarounds
- whether that pain is severe enough to justify a new overlay product

The matter type may be real and still not be commercially dense enough.

### 3. I do not yet believe the product is obviously better than internal build or incumbent extension

The market whitespace is clearer now.

The unfairness is not.

It is still easy to imagine a buyer saying:

- "we should build this on ServiceNow"
- "we should extend what we have in Veeva"
- "we should model this in our data platform and dashboards"

That means the product still needs a stronger answer to:

why buy Sentinel instead of extending the stack already in place?

### 4. I do not yet believe the day-one logic is safe from drifting into services

Even the narrowed design still carries real productization risk.

Jurisdictions, clocks, responsible parties, evidence, and downstream routing are the right concepts.

They are also the kind of concepts that can quietly become customer-specific consulting if not handled very carefully.

### 5. I am not fully convinced the first proof must cross a jurisdiction boundary

That requirement makes the story strategically sharper.

It may also make the first pilot harder than necessary.

There is a real chance that proving the coordination model on a simpler single-market cross-system issue would be commercially easier, even if it is strategically less elegant.

## What This Means

My current position is:

Sentinel now looks like a plausible wedge, but not yet an earned company.

That is a much better place than being a vague platform fantasy.

But it is still a fragile place.

The next phase should not be more abstract vision work for its own sake.

The next phase should be demand validation work.

## Must Prove Next

### 1. Who can actually buy it

We need to know:

- who would sponsor the first pilot
- who owns the budget
- who can approve a coordination overlay
- whether the user sponsor and economic buyer are the same person or not

If no credible budget owner emerges, the wedge may stay intellectually strong and commercially weak.

### 2. Whether the chosen matter type is frequent and painful enough

We need evidence for:

- recurrence
- operational severity
- cost of current workaround
- visibility of the pain to leadership

The matter type should not just be understandable.

It should be painful enough to motivate action.

### 3. Whether the buyer wants an overlay or really wants replacement

We need to learn whether design partners truly want:

- coordination state
- ownership clarity
- obligation visibility
- evidence reconstruction

or whether they actually want:

- better case processing
- better submission transport
- better dashboards
- broader workflow modernization

Those are very different products.

### 4. Whether the first proof can stay inside a stable core model

We need to see whether repeated examples of the chosen matter type can use the same core primitives without introducing many new core entities.

If they cannot, the wedge is drifting toward services.

### 5. Whether the product can win before many integrations are required

We need to know the smallest number of systems and teams required for the first pilot to matter.

If the pilot needs many integrations before value appears, adoption will get much harder.

### 6. Whether a simpler first proof would be wiser

We should still test whether the first implementation really needs cross-jurisdiction complexity on day one.

A simpler first proof may:

- shorten time to value
- reduce modeling risk
- make design-partner adoption easier

The downside is that it may weaken the strategic story.

That tradeoff should be tested rather than assumed.

## Working Decision Rule

Keep pursuing Sentinel if most of these start becoming true:

- a real economic buyer emerges
- the chosen matter type is visibly recurring
- the current workaround is painful enough to motivate buying behavior
- the buyer wants an overlay rather than replacement
- the pilot can prove value with a stable core model and limited integrations

Slow down or reframe if most of these remain false.

## Practical Summary

The project is now much stronger intellectually.

It is still unproven commercially.

That means the right next move is not to abandon the idea.

It is to stop pretending that clarity of vision alone is validation and to force the next round of work to answer demand questions, not just design questions.
